Now showing items 1-1 of 1
Egfr inhibition in a pretreated sacral chordoma: a rolefor erlotinib? Case report and a brief review of literature
We describe the case of a 69-year old male with an EGFR- positive Imatinib refractory sacral chordoma with synchronous lung metastases, treated with erlotinib, a first- generation EGFR inhibitor. After disease progression ...